American College of Rheumatology @ , @ , and @ responses achieved during the DB period were maintained through the LTE , and on Day @ were @ % ( @ % CI @ , @ ) , @ % ( @ % CI @ , @ ) , and @ % ( @ % CI @ , @ ) for patients who kept taking SC ABA , and @ % ( @ % CI @ , @ ) , @ % ( @ % CI @ , @ ) , and @ % ( @ % CI @ , @ ) for those who switched from IV to SC ABA .